1Ruepert L, Quartero AO, de Wit NJ, et al. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2011 ,(8): CD003460.
2Adeyemo MA, Spiegel BM, Chang L, et al. Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Aliment Pharmacol Thor, 2010,32: 738-755.
3Wilson A, Longsh'eth GF, Knight K, ct al. Quality of life in managed care patients with irritable bowel syndrome. Manager Care Interface, 2004,17:24-28, 34.
4Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med, 20i 1,62:381-396.
5Dinah TG, Quigley EM, Ahmed SM, et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology, 2006, 130:304-311.
9Delafoy L, Gelot A, Ardid D, et al. Interactive involvement of brain derived nourotrophic factor, nerve growth factor, and calciton in gene related pep tide in colonic hypersensitivity in the rat. Gut, 2006,55(7) : 940-945.
10Barreau F, Cartier C, Leveque M, et al. Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin-releasing factor and nerve growth factor interplay. J Physiol 2007, 580( Pt 1) : 347-356.
